NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index.
The underlying index measures the performance of the healthcare sector of theU. S. equity market.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 1000.00% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 12.00% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 8.96% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.88% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.80% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 4.24% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.11% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.43% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.26% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.06% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.77% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.59% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.59% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.52% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.41% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.33% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.25% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 2.11% |
| ELV | Elevance Health Inc | Healthcare | Healthcare Plans | 1.87% |
| CI | Cigna Corp | Healthcare | Healthcare Plans | 1.66% |